Literature DB >> 28848826

Fibrinogen and COPD: Now what?

Rosa Faner1,2, Alvar Agusti1,2,3.   

Abstract

Entities:  

Keywords:  biomarkers; copd; fibrinogen

Year:  2015        PMID： 28848826      PMCID： PMC5560468          DOI： 10.15326/jcopdf.2.1.2014.0127

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN： 2372-952X


× No keyword cloud information.
  21 in total

Review 1.  Statins as adjunct therapy in COPD: how do we cope after STATCOPE?

Authors:  Robert P Young; Raewyn J Hopkins; Alvar Agusti
Journal:  Thorax       Date:  2014-07-11       Impact factor: 9.139

Review 2.  Biomarkers in COPD.

Authors:  Alvar Agusti; Don D Sin
Journal:  Clin Chest Med       Date:  2013-12-12       Impact factor: 2.878

Review 3.  The path to personalised medicine in COPD.

Authors:  Alvar Agusti
Journal:  Thorax       Date:  2014-04-29       Impact factor: 9.139

4.  Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPD.

Authors:  David M Mannino; Ruth Tal-Singer; David A Lomas; Jorgen Vestbo; R Graham Barr; Kay Tetzlaff; Michael Lowings; Stephen I Rennard; Jeffrey Snyder; Mitchell Goldman; Ubaldo J Martin; Deborah Merrill; Amber L Martin; Jason C Simeone; Kyle Fahrbach; Brian Murphy; Nancy Leidy; Bruce Miller
Journal:  Chronic Obstr Pulm Dis       Date:  2015

Review 5.  Mortality in COPD: Role of comorbidities.

Authors:  D D Sin; N R Anthonisen; J B Soriano; A G Agusti
Journal:  Eur Respir J       Date:  2006-12       Impact factor: 16.671

6.  Systemic and airway inflammation and the presence of emphysema in patients with COPD.

Authors:  Andriana I Papaioannou; Argyro Mazioti; Theodoros Kiropoulos; Irini Tsilioni; Angela Koutsokera; Kalliopi Tanou; Dimitrios J Nikoulis; Panagiotis Georgoulias; Epameinondas Zakynthinos; Konstantinos I Gourgoulianis; Konstantinos Kostikas
Journal:  Respir Med       Date:  2009-10-24       Impact factor: 3.415

Review 7.  The COPD control panel: towards personalised medicine in COPD.

Authors:  Alvar Agusti; William MacNee
Journal:  Thorax       Date:  2012-11-01       Impact factor: 9.139

8.  Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease.

Authors:  Miguel Divo; Claudia Cote; Juan P de Torres; Ciro Casanova; Jose M Marin; Victor Pinto-Plata; Javier Zulueta; Carlos Cabrera; Jorge Zagaceta; Gary Hunninghake; Bartolome Celli
Journal:  Am J Respir Crit Care Med       Date:  2012-05-03       Impact factor: 21.405

9.  Simvastatin for the prevention of exacerbations in moderate-to-severe COPD.

Authors:  Gerard J Criner; John E Connett; Shawn D Aaron; Richard K Albert; William C Bailey; Richard Casaburi; J Allen D Cooper; Jeffrey L Curtis; Mark T Dransfield; MeiLan K Han; Barry Make; Nathaniel Marchetti; Fernando J Martinez; Dennis E Niewoehner; Paul D Scanlon; Frank C Sciurba; Steven M Scharf; Don D Sin; Helen Voelker; George R Washko; Prescott G Woodruff; Stephen C Lazarus
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245

10.  C-reactive protein, fibrinogen, and cardiovascular disease prediction.

Authors:  Stephen Kaptoge; Emanuele Di Angelantonio; Lisa Pennells; Angela M Wood; Ian R White; Pei Gao; Matthew Walker; Alexander Thompson; Nadeem Sarwar; Muriel Caslake; Adam S Butterworth; Philippe Amouyel; Gerd Assmann; Stephan J L Bakker; Elizabeth L M Barr; Elizabeth Barrett-Connor; Emelia J Benjamin; Cecilia Björkelund; Hermann Brenner; Eric Brunner; Robert Clarke; Jackie A Cooper; Peter Cremer; Mary Cushman; Gilles R Dagenais; Ralph B D'Agostino; Rachel Dankner; George Davey-Smith; Dorly Deeg; Jacqueline M Dekker; Gunnar Engström; Aaron R Folsom; F Gerry R Fowkes; John Gallacher; J Michael Gaziano; Simona Giampaoli; Richard F Gillum; Albert Hofman; Barbara V Howard; Erik Ingelsson; Hiroyasu Iso; Torben Jørgensen; Stefan Kiechl; Akihiko Kitamura; Yutaka Kiyohara; Wolfgang Koenig; Daan Kromhout; Lewis H Kuller; Debbie A Lawlor; Tom W Meade; Aulikki Nissinen; Børge G Nordestgaard; Altan Onat; Demosthenes B Panagiotakos; Bruce M Psaty; Beatriz Rodriguez; Annika Rosengren; Veikko Salomaa; Jussi Kauhanen; Jukka T Salonen; Jonathan A Shaffer; Steven Shea; Ian Ford; Coen D A Stehouwer; Timo E Strandberg; Robert W Tipping; Alberto Tosetto; Sylvia Wassertheil-Smoller; Patrik Wennberg; Rudi G Westendorp; Peter H Whincup; Lars Wilhelmsen; Mark Woodward; Gordon D O Lowe; Nicholas J Wareham; Kay-Tee Khaw; Naveed Sattar; Chris J Packard; Vilmundur Gudnason; Paul M Ridker; Mark B Pepys; Simon G Thompson; John Danesh
Journal:  N Engl J Med       Date:  2012-10-04       Impact factor: 91.245
View more
  2 in total

1.  Association of chronic inflammation with cardiovascular risk in chronic obstructive pulmonary disease-A cross-sectional study.

Authors:  Đivo Ljubičić; Vedran Balta; Dario Dilber; Hrvoje Vražić; Domagoj Đikić; Dyana Odeh; Jasna Čerkez Habek; Emilija Lozo Vukovac; Neven Tudorić
Journal:  Health Sci Rep       Date:  2022-04-07

Review 2.  Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations.

Authors:  Andrew I Ritchie; Jadwiga A Wedzicha
Journal:  Clin Chest Med       Date:  2020-09       Impact factor: 2.878
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.